Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR2 | P30874 | 16/20 | 0.88 |
| ▸ | SSTR5 | P35346 | 15/20 | 0.87 |
| ▸ | SSTR4 | P31391 | 8/20 | 0.83 |
| ▸ | SSTR3 | P32745 | 5/20 | 0.78 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24211760 | 1.00 | SSTR2 (0.88) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL17404630 | 1.00 | SSTR2 (0.88) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL30379842 | 1.00 | SSTR2 (0.88) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL24588414 | 1.00 | SSTR2 (0.88) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL29383799 | 1.00 | SSTR2 (0.88) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL18712689 | 0.97 | SSTR2 (0.83) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL29359873 | 0.97 | SSTR5 (0.92) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL26270883 | 0.97 | SSTR5 (0.92) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL19542369 | 0.97 | SSTR2 (0.82) | SSTR2SSTR5SSTR4SSTR3SSTR1 | |
| SCHEMBL31632616 | 0.97 | SSTR2 (0.83) | SSTR2SSTR5SSTR4SSTR3SSTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11684682-B2 | Chelating AAZTA conjugates and complexes thereof | BRACCO IMAGING S.P.A. (IT) | 2023-06-27 | — | — | US | disclosed |
| US-20220016275-A1 | CHELATING AAZTA CONJUGATES AND COMPLEXES THEREOF | BRACCO IMAGING S.P.A. (IT) | 2022-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11684682-B2 | Chelating AAZTA conjugates and complexes thereof | SLC39A11, SLC30A5, SLC39A14 | SSTR2 1784/4885SSTR5 251/4885SSTR4 967/4885 |
| US-20220016275-A1 | CHELATING AAZTA CONJUGATES AND COMPLEXES THEREOF | SLC39A11, SLC30A5, SLC39A14 | SSTR2 1784/4885SSTR5 251/4885SSTR4 967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.